Exome sequencing in individuals with congenital anomalies of the kidney and urinary tract (CAKUT): a single-center experience.


Journal

European journal of human genetics : EJHG
ISSN: 1476-5438
Titre abrégé: Eur J Hum Genet
Pays: England
ID NLM: 9302235

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 08 11 2022
accepted: 28 02 2023
revised: 27 02 2023
medline: 12 6 2023
pubmed: 17 3 2023
entrez: 16 3 2023
Statut: ppublish

Résumé

Individuals with congenital anomalies of the kidney and urinary tract (CAKUT) show a broad spectrum of malformations. CAKUT can occur in an isolated fashion or as part of a syndromic disorder and can lead to end-stage kidney failure. A monogenic cause can be identified in ~12% of affected individuals. This study investigated a single-center CAKUT cohort analyzed by exome sequencing (ES). Emphasis was placed on the question whether diagnostic yield differs between certain CAKUT phenotypes (e.g., bilateral kidney affection, unilateral kidney affection or only urinary tract affection). 86 unrelated individuals with CAKUT were categorized according to their phenotype and analyzed by ES to identify a monogenic cause. Prioritized variants were rated according to the recommendations of the American College of Medical Genetics and Genomics and the Association for Clinical Genomic Science. Diagnostic yields of different phenotypic categories were compared. Clinical data were collected using a standardized questionnaire. In the study cohort, 7/86 individuals had a (likely) pathogenic variant in the genes PAX2, PBX1, EYA1, or SALL1. Additionally, in one individual, a 17q12 deletion syndrome (including HNF1B) was detected. 64 individuals had a kidney affection, which was bilateral in 36. All solved cases (8/86, 9%) had bilateral kidney affection (diagnostic yield in subcohort: 8/36, 22%). Although the diagnostic yield in CAKUT cohorts is low, our single-center experience argues, that, in individuals with bilateral kidney affection, monogenic burden is higher than in those with unilateral kidney or only urinary tract affection.

Identifiants

pubmed: 36922632
doi: 10.1038/s41431-023-01331-x
pii: 10.1038/s41431-023-01331-x
pmc: PMC10250376
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

674-680

Informations de copyright

© 2023. The Author(s).

Références

J Am Soc Nephrol. 2018 Sep;29(9):2348-2361
pubmed: 30143558
Bioinformatics. 2012 Nov 1;28(21):2747-54
pubmed: 22942019
J Am Soc Nephrol. 2018 Jan;29(1):36-50
pubmed: 29079659
J Clin Invest. 2018 Jan 2;128(1):4-15
pubmed: 29293093
Nat Genet. 2019 Jan;51(1):117-127
pubmed: 30578417
Hum Mutat. 2018 Nov;39(11):1517-1524
pubmed: 30192042
PLoS Genet. 2009 Jan;5(1):e1000353
pubmed: 19165332
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Pediatr Nephrol. 2013 Nov;28(11):2143-7
pubmed: 23812353
Nephrology (Carlton). 2015 Jun;20(6):413-8
pubmed: 25645028
Nat Rev Nephrol. 2015 Dec;11(12):720-31
pubmed: 26281895
J Am Soc Nephrol. 2017 Oct;28(10):2901-2914
pubmed: 28566479
Nat Commun. 2017 Jun 12;8:15824
pubmed: 28604674
Hum Mutat. 2018 Dec;39(12):1854-1860
pubmed: 30260545
Pediatr Nephrol. 2014 Apr;29(4):695-704
pubmed: 24398540
Clin J Am Soc Nephrol. 2020 May 7;15(5):723-731
pubmed: 32188635
Genet Med. 2017 Apr;19(4):412-420
pubmed: 27657687
Genet Med. 2011 Jul;13(7):680-5
pubmed: 21681106
Pediatr Nephrol. 2022 Oct;37(10):2231-2243
pubmed: 35122119
Genet Med. 2014 Dec;16(12):962-71
pubmed: 24901348
Clin Genet. 2018 Apr;93(4):860-869
pubmed: 29194579
J Am Soc Nephrol. 2017 Jan;28(1):69-75
pubmed: 27151922
Pediatr Nephrol. 2011 Mar;26(3):353-64
pubmed: 20798957
Kidney Int. 2014 Apr;85(4):880-7
pubmed: 24257694
Nat Genet. 2014 Mar;46(3):299-304
pubmed: 24509478
Kidney Int. 2012 Jan;81(2):196-200
pubmed: 21900877
Nephrol Dial Transplant. 2011 Jan;26(1):136-43
pubmed: 20605837

Auteurs

Korbinian M Riedhammer (KM)

Institute of Human Genetics, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.
Department of Nephrology, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.

Jasmina Ćomić (J)

Institute of Human Genetics, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.
Department of Nephrology, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.

Velibor Tasic (V)

University Children's Hospital, Medical Faculty of Skopje, Skopje, North Macedonia.

Jovana Putnik (J)

Institute for Mother and Child Health Care of Serbia "Dr Vukan Čupić", Department of Nephrology, University of Belgrade, Faculty of Medicine, Belgrade, Serbia.

Nora Abazi-Emini (N)

University Children's Hospital, Medical Faculty of Skopje, Skopje, North Macedonia.

Aleksandra Paripovic (A)

Institute for Mother and Child Health Care of Serbia "Dr Vukan Čupić", Department of Nephrology, University of Belgrade, Faculty of Medicine, Belgrade, Serbia.

Natasa Stajic (N)

Institute for Mother and Child Health Care of Serbia "Dr Vukan Čupić", Department of Nephrology, University of Belgrade, Faculty of Medicine, Belgrade, Serbia.

Thomas Meitinger (T)

Institute of Human Genetics, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.

Valbona Nushi-Stavileci (V)

Pediatric Clinic, University Clinical Center of Kosovo, Prishtina, Kosovo.

Riccardo Berutti (R)

Institute of Human Genetics, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.

Matthias C Braunisch (MC)

Department of Nephrology, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.

Julia Hoefele (J)

Institute of Human Genetics, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany. julia.hoefele@tum.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH